Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts by den Exter, Paul L et al.








Establishing diagnostic criteria and treatment of subsegmental pulmonary
embolism: A Delphi analysis of experts
den Exter, Paul L ; Kroft, Lucia J M ; Gonsalves, Carol ; Le Gal, Gregoire ; Schaefer-Prokop, Cornelia
M ; et al ; Barco, Stefano
Abstract: Background Improved imaging techniques have increased the incidence of subsegmental pul-
monary embolism (ssPE). Indirect evidence is suggesting that ssPE may represent a more benign presen-
tation of venous thromboembolism not necessarily requiring anticoagulant treatment. However, correctly
diagnosing ssPE is challenging with reported low interobserver agreement, partly due to the lack of widely
accepted diagnostic criteria. Objectives We sought to derive uniform diagnostic criteria for ssPE, guided
by expert consensus. Methods Based on an extensive literature review and expert opinion of a Del-
phi steering committee, two surveys including statements regarding diagnostic criteria and management
options for ssPE were established. These surveys were conducted electronically among two panels, re-
spectively: expert thoracic radiologists and clinical venous thromboembolism specialists. The Delphi
method was used to achieve consensus after multiple survey rounds. Consensus was defined as a level
of agreement >70%. Results Twenty-nine of 40 invited radiologists (73%) and 40 of 51 clinicians (78%)
participated. Following two survey rounds by the expert radiologists, consensus was achieved on 15 of 16
statements, including on the established diagnostic criteria for ssPE (96% agreement): a contrast defect
in a subsegmental artery, that is, the first arterial branch division of any segmental artery independent
of artery diameter, visible in at least two subsequent axial slices, using a computed tomography scanner
with a desired maximum collimator width of ฀1 mm. These criteria were approved by 83% of the clinical
venous thromboembolism (VTE) specialists. The clinical expert panel favored anticoagulant treatment
in case of prior VTE, antiphospholipid syndrome, pregnancy, cancer, and proximal deep vein thrombo-
sis. Conclusion The results of this analysis provide standard radiological criteria for ssPE that may be
applicable in both clinical trials and practice.
DOI: https://doi.org/10.1002/rth2.12422






The following work is licensed under a Creative Commons: Attribution-NonCommercial-NoDerivatives
4.0 International (CC BY-NC-ND 4.0) License.
Originally published at:
den Exter, Paul L; Kroft, Lucia J M; Gonsalves, Carol; Le Gal, Gregoire; Schaefer-Prokop, Cornelia
M; et al; Barco, Stefano (2020). Establishing diagnostic criteria and treatment of subsegmental pul-




Res Pract Thromb Haemost. 2020;4:1251–1261.    |  1251wileyonlinelibrary.com/journal/rth2
 
Received: 19 May 2020  |  Revised: 25 June 2020  |  Accepted: 4 July 2020
DOI: 10.1002/rth2.12422  
O R I G I N A L  A R T I C L E
Establishing diagnostic criteria and treatment of subsegmental 
pulmonary embolism: A Delphi analysis of experts
Paul L. den Exter MD, PhD1 |   Lucia J. M. Kroft MD, PhD2 |    
Carol Gonsalves MD, FRCPC, MMEd3 |   Gregoire Le Gal MD, PhD3  |    
Cornelia M. Schaefer-Prokop MD, PhD4,5 |   Marc Carrier MD, MSc, FRCPC3  |    
Menno V. Huisman MD, PhD1 |   Frederikus A. Klok MD, PhD1
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in 
any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
© 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis 
and Haemostasis.
1Department of Thrombosis and 
Hemostasis, Leiden University Medical 
Center, Leiden, The Netherlands
2Department of Radiology, Leiden University 
Medical Center, Leiden, The Netherlands
3Department of Medicine, Ottawa Hospital 
Research Institute at the University of 
Ottawa, Ontario, Canada
4Diagnostic Image Analysis Group, 
Department of Radiology and Nuclear 
Medicine, Radboud University Medical 
Center, Nijmegen, The Netherlands
5Department of Radiology, Meander 
Medisch Centrum, Amersfoort, The 
Netherlands
Correspondence
Frederikus A. Klok, Department of 
Thrombosis and Hemostasis, Leiden 
University Medical Center, Room C-7-




G. Le Gal is the recipient of an Early 
Researcher Award from the Province of 
Ontario, a Heart and Stroke Foundation of 
Canada Ontario Mid-Career Investigator 
Award, and holds the Chair on Diagnosis 
of Venous Thromboembolism from the 
Department of Medicine, University of 
Ottawa.
Handling Editor: Dr Susan Kahn. 
Abstract
Background: Improved imaging techniques have increased the incidence of subseg-
mental pulmonary embolism (ssPE). Indirect evidence is suggesting that ssPE may 
represent a more benign presentation of venous thromboembolism not necessarily 
requiring anticoagulant treatment. However, correctly diagnosing ssPE is challenging 
with reported low interobserver agreement, partly due to the lack of widely accepted 
diagnostic criteria.
Objectives: We sought to derive uniform diagnostic criteria for ssPE, guided by ex-
pert consensus.
Methods: Based on an extensive literature review and expert opinion of a Delphi 
steering committee, two surveys including statements regarding diagnostic criteria 
and management options for ssPE were established. These surveys were conducted 
electronically among two panels, respectively: expert thoracic radiologists and clini-
cal venous thromboembolism specialists. The Delphi method was used to achieve 
consensus after multiple survey rounds. Consensus was defined as a level of agree-
ment >70%.
Results: Twenty-nine of 40 invited radiologists (73%) and 40 of 51 clinicians (78%) 
participated. Following two survey rounds by the expert radiologists, consensus was 
achieved on 15 of 16 statements, including on the established diagnostic criteria for 
ssPE (96% agreement): a contrast defect in a subsegmental artery, that is, the first ar-
terial branch division of any segmental artery independent of artery diameter, visible 
in at least two subsequent axial slices, using a computed tomography scanner with a 
desired maximum collimator width of ≤1 mm. These criteria were approved by 83% 
of the clinical venous thromboembolism (VTE) specialists. The clinical expert panel 
favored anticoagulant treatment in case of prior VTE, antiphospholipid syndrome, 
pregnancy, cancer, and proximal deep vein thrombosis.
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Essentials
• Establishing a subsegmental pulmonary embolism diagnosis is challenging.
• Surveys were conducted among expert thoracic radiologists and clinical thrombosis specialists.
• Delphi analysis provided uniform diagnostic criteria to diagnose subsegmental pulmonary embolism.
• Anticoagulant treatment was favored for prior venous thromboembolism, antiphospholipid syndrome, pregnancy, cancer, and proximal 
deep vein thrombosis.
1  | INTRODUCTION
Multidetector computed tomographic pulmonary angiography 
(CTPA) has evolved as the imaging test of choice in the diagnos-
tic workup of clinically suspected pulmonary embolism (PE).1 As 
CTPA allows better visualization of peripheral pulmonary arter-
ies compared to previously used imaging techniques, small emboli 
isolated to subsegmental branches of the pulmonary artery tree 
are increasingly being detected.2-4 The rate of these so-called 
subsegmental PE (ssPE) diagnoses has been reported to have al-
most doubled to 9%, when earlier studies were compared to more 
recent studies using computed tomography (CT) scans with more 
detector rows.5 Considering that a proportion of ssPE diagnoses 
would have gone undetected and thus left untreated with former 
imaging techniques, the clinical significance of these findings is 
subject to debate. Some observational case series have indeed 
provided some ground for leaving ssPE untreated in the setting of 
low risk of (recurrent) venous thromboembolism (VTE) and in the 
absence of deep vein thrombosis (DVT) of the leg.6,7 On the other 
hand, unselected patients with ssPE have been described to have 
a risk of recurrent VTE comparable to that of patients with more 
proximal PE.8
Establishing a radiological diagnosis of ssPE is challenging, as 
demonstrated by a retrospective cohort study in which 11% of rou-
tinely established ssPE diagnoses were reinterpreted to be with-
out any evidence of PE, while on the other hand, 37% of patients 
initially diagnosed with ssPE were reinterpreted to have more 
proximal PE.9 As a false-positive ssPE diagnosis may come with 
the consequence of unnecessary anticoagulant treatment and its 
associated potential harms, establishing a correct diagnosis is of ut-
most importance.10 Moreover, clinical trials aimed at assessing the 
optimal management of ssPE would be invalid should the diagnosis 
not be reproducible.
One of the possible explanations of the poor interobserver 
reliability for the diagnosis of ssPE is the lack of widely accepted 
and reproducible diagnostic criteria as well as the existence of re-
lated terms such as incidental and isolated. We therefore sought to 
establish uniform diagnostic criteria for ssPE, guided by systematic 
review of the literature and consensus of expert thoracic radiolo-
gists. Second, we aimed to propose these criteria to clinical VTE 
specialists and to establish consensus of current best practice with 
regard to the therapeutic management of ssPE.
2  | METHODS
2.1 | Study design
The Delphi method was used to assess expert consensus among 
a panel of thoracic radiologists and VTE specialists. This is a 
well-accepted and widely used structured process to build con-
sensus through opinions and feedback from a group of informed ex-
perts.11-13 It is an anonymous process where a predefined research 
problem, usually lacking empirical evidence, is expressed to an ex-
pert panel in the form of a questionnaire. Responses are collated 
and analyzed, and the process usually continues for several rounds 
until the best possible level of consensus is achieved.14 The experts 
are allowed to adjust their answers in subsequent rounds, based on 
how they interpret the results of the expert panel as whole, which 
are provided to them.
The Conducting and Reporting Delphi Studies guidelines were 
followed for the conducting and reporting of this Delphi study.15
2.2 | Selection of experts
This Delphi analysis consisted of two parts. The first part was de-
signed to establish radiological criteria for a CTPA diagnosis of ssPE, 
and the second to propose these criteria to clinical VTE specialists 
and to establish consensus of current best practice about the treat-
ment of ssPE.
For the first part of the Delphi analysis, expert radiologists were 
selected based on the following criteria: (i) leaders in the field of clin-
ical thoracic radiology as demonstrated by a strong publication track 
Conclusion: The results of this analysis provide standard radiological criteria for ssPE 
that may be applicable in both clinical trials and practice.
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record, (ii) preferably being member of the Fleischner society, and 
(iii) currently practicing and/or involved in the training of resident ra-
diologists. For the second part, clinical VTE specialists were selected 
based on the following criteria: (i) leaders in the field of diagnosis and 
management of VTE as demonstrated by a strong publication track 
record, (ii) preferably being member of ISTH or the American Society 
of Hematology, and (iii) currently practicing and/or involved in the 
training of resident clinicians.
Both expert panels were selected to represent a wide geographic 
area and to include both females and males. The experts completed 
the questionnaire anonymously and were unaware of the identity of 
the other involved experts.
2.3 | Delphi process and steering committee
A multinational Delphi steering committee of eight members was 
established to oversee the process: six clinical experts on venous 
thromboembolism (PE, MC, CG, FK, MH, GG) and two thoracic 
radiological experts (LK and CSP). In cooperation with a trained 
medical librarian, a comprehensive literature review (Appendix 1) 
was performed by two members (PE and FK) to search for current 
recommendations in diagnosing PE and, in particular, ssPE. Based 
on the findings of this review and input from the steering com-
mittee, a first version of the Delphi questionnaire was drafted by 
two members (PE and FK). All members of the steering committee, 
both the clinical VTE experts and the expert radiologists, provided 
feedback on the questionnaire and approved its final version. For 
Part I of our Delphi study, this resulted in a total of 16 statements 
with primarily multiple-choice questions (Appendix 2). Each ques-
tion included a free text box for comments. A final open question 
was included, which allowed the expert panel to provide input on 
the best systematic approach for reporting the results of CTPA in 
the setting of suspected pulmonary embolism with regard to the 
subsegmental arteries. Subsequent rounds were planned until con-
sensus would have been reached. Following completion of Part I, a 
second survey (Part II) was constructed with an aim to survey clini-
cal VTE experts. Again, a first version of the Delphi questionnaire 
was drafted by two members (PE and FK). All members of the steer-
ing committee provided feedback on the questionnaire and ap-
proved its final version. This resulted in seven questions that were 
constructed to survey their clinical management approach. In addi-
tion, the final results of Part I of the Delphi analysis were provided 
to the clinical expert panel, to assess whether they would agree 
with the proposed diagnostic criteria. Subsequent rounds were 
planned until consensus would have been reached. Consensus in 
both Parts I and II of the Delphi analysis was defined as a minimum 
level of agreement of 70%, in line with previous Delphi reports.16-19 
We planned any number of consecutive Delphi rounds to achieve 
this consensus. The Delphi process was undertaken with the use of 
an online survey tool (SurveyMonkey). Responses were filed at the 
experts’ discretion until a given deadline. Two reminders were sent 
before reaching the deadline.
2.4 | Hypothesis
The normal anatomy of the pulmonary artery follows that of the 
bronchial anatomy. The main pulmonary artery arises at the base of 
the right ventricle and extends superiorly for approximately 5 cm 
before dividing in into the right and left pulmonary artery (Figure 1). 
The right main pulmonary artery usually divides into an ascending 
upper lobe artery and a descending interlobar artery that gives rise 
to the middle and right lower lobe arteries. The left main pulmo-
nary artery, after giving rise to the left upper lobe artery, usually de-
scends and gives rise to the (segmental) lingual arteries and left lower 
lobe artery. Pulmonary arteries divide by dichotomous branching. 
Overall, approximately 17 of these divisions are usually present. The 
further branching of lobar, segmental, and subsegmental pulmonary 
arteries show considerable variation. To identify a specific lobar or 
segmental artery branch, it is usually necessary to identify its associ-
ated bronchus.
The subsegmental pulmonary arteries may have a diameter of 
up to 6-7 mm in diameter just after the initial branch, decreasing to 
<1.5 mm in the peripheral lung.20,21 Vessels smaller than this range 
are labeled arterioles and are not visible on standard CTPA images, 
which normally allows detection of arteries as small as 2 mm in di-
ameter. A prerequisite to identify subsegmental PE is the clear and 
doubtless identification of the subsegmental vessels with an intra-
luminal contrast defect. The contrast defect can be local and sur-
rounded by intravascular contrast or lead to a complete obstruction 
and thus cutoff of the vessel. It has been demonstrated that 98% 
of subsegmental arteries could be identified using 64-row multide-
tector computed tomography scanners with 1.2 mm collimation and 
0.5 mm ultrathin reconstructed effective slice thickness.22 Anatomic 
regions that are not adequately depicted correspond mostly to pa-
racardiac anatomic locations that are exposed to the motion of the 
beating heart muscle with resulting artefacts.
Consequently, we hypothesized that radiological criteria for ssPE 
should involve the following aspects: (i) technical quality of the scan 
(eg, contrast timing, artefacts, identification of all subsegmental ar-
teries), (ii) anatomic location (ie, correlation to bronchus and number 
of side branches from the lobar artery), and (c) artery diameter. This 
hypothesis was the basis of the first part of the Delphi analysis.
2.5 | Analysis
Descriptive statistics were calculated using SPSS version 25.0.0 
(IBM, Armonk, NY, USA).
3  | RESULTS
3.1 | Literature search
The systematic literature review was performed on October 30, 
2017, and resulted in a total of 280 eligible articles. Based on the 
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titles and abstracts, 32 articles were selected for complete review. 
Diagnostic criteria for a CTPA diagnosis of ssPE could not be ex-
tracted from any of the articles.
3.2 | Delphi Part I: Radiological definition
In October 2018, the first round of the Delphi questionnaire was 
distributed among 40 expert radiologists. Of those, 29 consented to 
participate and completed the questionnaire (73%). The expert panel 
included radiologists practicing in 12 different countries; 27 of 29 
participants completed the full Delphi procedure.
Following compilation of the results of the online survey, consen-
sus was reached on 8 of 16 statements (Figure 2). A vast majority of 
experts (89%) agreed that the diagnostic criteria for ssPE should be 
based on the anatomic location within the pulmonary arterial sys-
tem alone and not on the vessel diameter of the pulmonary artery 
affected. This was reinforced by another statement in which the ex-
pert panel agreed (78%) that the diameter of a certain affected pul-
monary artery branch does not contribute to the definition of ssPE. 
Technical specifications of the CT scanner, a minimum Hounsfield 
Unit, or maximal collimator width were not considered to be relevant 
either. Also, 82% of the experts agreed that the term isolated ssPE 
refers to a solitary embolus in a single subsegmental artery without 
the presence of other ssPEs or additional emboli more centrally.
The statements for which consensus was not achieved were dis-
cussed within the Delphi steering committee, modified, and sent for 
a secondary survey round. In this second round, respondents were 
able to see which of the multiple-choice options achieved the highest 
level of consensus. The second survey consisted of nine statements 
with multiple-choice answers and were answered by all responders 
of the first round. Eight of the nine statements achieved consensus 
(Figure 3). Based on the results of the Delphi, we constructed the 
following diagnostic criteria for ssPE on CTPA: “A contrast defect 
in a subsegmental artery, ie, the first arterial branch division of any 
segmental artery independent of artery diameter, visible in at least 
two subsequent axial slices, using a CT scanner with a desired maxi-
mum collimator width of ≤1 mm.” The agreement on specific recom-
mendations for confirming and reporting of ssPE is summarized in 
Table 1. A total of 96% of the participants approved these diagnostic 
criteria and recommendations.
3.3 | Delphi Part II: Therapeutic management
In February 2019, the first round of the Delphi questionnaire was 
distributed among 51 clinical VTE specialists. Of those, 40 con-
sented to participate and completed the questionnaire (78%). The 
expert panel included clinicians practicing in 11 different countries; 
39 of 40 participants completed the full Delphi procedure.
The results of Part II of the Delphi analysis are depicted in 
Figure 4. A majority of 83% of the experts agreed with the pro-
posed diagnostic criteria derived from the first part of the Delphi. 
They also agreed on the statement that the diameter of the af-
fected vessel does not contribute to the diagnosis or treatment 
of ssPE (97% consensus). Of the respondents who did not agree 
with the diagnostic criteria, three commented that the definition 
isolated ssPE should include the absence of (proximal) DVT. Two 
respondents commented that “sufficient contrast” should be spec-
ified. One suggested that the number and location of subsegmental 
F I G U R E  1   Schematic overview of anatomy of the pulmonary artery; green branches represent main and interlobar arteries, blue 
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emboli should always be included in the report. For one respon-
dent, it was unclear why the phrase “first arterial branch” was 
needed in the definition. One final respondent suggested to add: 
“A contrast defect in a subsegmental or lower/smaller/further out 
artery.”
Over two Delphi rounds, the second round answered by all the 
responders of the first round, agreement of >70% was achieved that 
incidental and symptomatic ssPE may be left untreated in the ab-
sence of the following five conditions: previous VTE, antiphospho-
lipid syndrome, pregnancy, active malignancy, and asymptomatic or 
symptomatic proximal DVT. The number of subsegmental emboli, 
that is, one or multiple, was not found to be a discriminative factor 
for the decision whether to start treatment. Therefore, the identified 
conditions necessitating anticoagulant treatment apply to both sin-
gle or multiple subsegmental pulmonary emboli. In case treatment 
was indicated, the expert panel agreed (77%) that the treatment du-
ration of ssPE should be the same as for more proximal PE in the set-
ting of a comparable thromboembolic risk profile. It was agreed that 
the preferred type of anticoagulant (eg, direct oral anticoagulants, 
vitamin K antagonists, or low-molecular-weight heparins) for ssPE 
should be the same as for more proximal PE.
Based on input from the expert panel during the first Delphi 
round, we additionally assessed the implications of the bleeding risk 
for the decision of whether to treat ssPE. It was agreed (90%) that 
the risk of bleeding complications should carry a greater weight in 
the decision of whether to treat a patient with ssPE with anticoag-
ulants, and for how long, than for comparable patients with more 
proximal PE.
4  | DISCUSSION
The results of this Delphi analysis have established a clear radio-
logical definition of ssPE with a high level of consensus among both 
thoracic radiological and clinical VTE experts. These criteria provide 
guidance in diagnostic and therapeutic decision making. Based on 
the second part of the Delphi, we also report best practice for the 
management of ssPE in specific settings as agreed upon by the ex-
pert clinicians.
Reported difficulties in diagnosing ssPE stress the need for uni-
form diagnostic criteria. Although clinical trials have reported the 
sensitivity of diagnosing ssPE on CTPA to be as high as 82%–100%, 
F I G U R E  2   Statements reaching consensus in the first round of the first part of the Delphi analysis. CTPA, computed tomographic 
pulmonary angiography; ssPE, subsegmental pulmonary embolism
The definition of subsegmental pulmonary embolism
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Yes, peripheral one third of segment.
Yes, peripheral 50% of segment.
Should the anatomic location (e.g., peripheral one third of the 
segment) be taken into the account for ssPE determination? 
Does perfusion imaging (dual energy or subtraction) help in 
reliably diagnosing ssPE? 
Can the diameter of a certain pulmonary artery branch 
be used to diagnose ssPE? 
Should the confidence in the diagnosis of ssPE be 
included into the report? 
What are the best window settings to evaluate ssPE? 
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this may decrease to 74% when considering single segmental or sub-
segmental pulmonary emboli.23 Interobserver agreement between 
radiologists in diagnosing ssPE has been shown to be low (κ = 0.38; 
95% CI, 0.0-0.89).24 In another study, reinterpretation by five ra-
diologists showed that at least one radiologist disagreed with the 
initial interpretation of ssPE in 60% of the cases.25 This might in part 
be explained by the high level of expertise that is necessary to di-
agnose ssPE. Indeed, it has been demonstrated that the sensitivity 
of ssPE diagnosis is higher among thoracic radiologists than among 
nonthoracic radiologists and that the diagnosis is more often cor-
rectly made among radiologists than among radiology residents.26-28
In contrast to our hypothesis, the expert radiologists were reso-
lute in their opinion that only the anatomic location of the contrast 
filling defect accounted for the definition of ssPE. The pulmonary ar-
tery diameter, which is known to be variable based on the anatomic 
location and dependent on anatomic variants and hemodynamic sta-
tus, was not considered to be relevant. The reason why we explicitly 
included the arterial diameter in the first Delphi round was that the 
anatomic definition of subsegmental refers to quite a wide range of 
arterial diameters from the fourth generation (main-lobar-segmen-
tal-subsegmental) of more centrally located arteries to very small 
peripheral arteries. This indeed allows for a more straightforward 
definition of ssPE when excluding artery diameter as input criteria, 
which represents a variable and difficult to reliably measure param-
eter. Of note, whether this definition leads to higher interobserver 
agreement and a decline in false-positive ssPE diagnoses remains to 
be demonstrated.
Image quality was also rejected as being relevant for the defi-
nition of ssPE. The expert radiologists did reach consensus on the 
statement that “the observer should verify whether and to which 
branching of the subsegmental arteries contrast enhancement is suf-
ficient to identify contrast defects at the subsegmental level before 
evaluation of the presence of subsegmental pulmonary embolism 
can be reliably performed.” This implies that the diagnosis cannot 
F I G U R E  3   Statements reaching consensus in the second round of the first part of the Delphi analysis. CTPA, computed tomographic 








ssPE is a filling defect in a subsegmental artery visible
in at least two subsequent axial slices.
The desired max. reconstructed slice thickness to
reliably diagnose ssPE is ≤1 mm.
The preferred approach of reading a CTPA to
diagnose ssPE is systematically, going from the center
to the periphery.
An observer should verify whether and to which branching of
subsegmental arteries contrast resolution is sufficient to identify
contrast defects on subsegmental level before evaluation of the
presence of ssPE can be reliably performed.
To diagnose ssPE with certainty, the presence of substantial motion
artefacts should be excluded. If the observer is not sure of the
diagnosis, this should be stated.
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TA B L E  1   Specific recommendations for confirming and 
reporting subsegmental pulmonary embolism
The observer should verify to which branching of the subsegmental 
arteries (eg, proximal, distal) contrast enhancement is sufficient to 
identify contrast defects on subsegmental level before evaluation 
of the presence of subsegmental pulmonary embolism can be 
reliably performed.
To diagnose subsegmental pulmonary embolism with certainty, 
the presence of substantial motion artefacts should be excluded, 
preferably in the “lung window,” in addition to affirmation of 
sufficient contrast enhancement. If the observer is not sure of the 
diagnosis, this should be stated in the report.
The term isolated subsegmental pulmonary embolism is reserved for 
a subsegmental pulmonary embolism in one subsegmental artery, 
and the term multiple subsegmental emboli refers to PE in two or 
more subsegmental arteries (or distal branches).”
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be reliably assessed in a certain segment if “sufficient contrast en-
hancement” is not reached. In such cases, assuming either an abnor-
mal D-dimer test or a high or likely clinical pretest probability,29 a 
repeat CTPA scan can be considered if it is likely that technical as-
pects and not limitations of the clinical status of the patient caused 
the limited quality of the examination. Alternatively, a scintigraphic 
examination can be considered. Importantly, consensus among ra-
diologists was reached to include the level of confidence into the 
diagnosis of isolated ssPE into the report, allowing for outweighing 
the risk of treatment versus a potentially false-positive diagnosis.
A remarkable observation in this study is that expert radiologists 
uniformly refer to “isolated ssPE” when it involves a single subseg-
mental embolus. This definition is more distinct than the one used in 
clinical studies, where isolated usually refers to one or multiple ssPEs 
without radiological evidence for more proximal PE or DVT.5,30 This 
difference in interpretation of ssPE terminology further strength-
ens the need for criteria that are universally applicable. Importantly, 
this new definition was approved by a majority of the clinical VTE 
experts. The fact that isolated refers to a single embolus means that 
irrespective of its location on a central or peripheral subsegmental 
artery, its resulting perfusion defect will be limited to a subsegmen-
tal area. This can be also seen as a further justification of the fact 
that the generation of a subsegmental artery and thus the diameter 
are not considered in the definition.
Until recently, anticoagulant treatment was the management 
approach of choice for any patient diagnosed with PE, regardless 
of its anatomic location. Whether patients with ssPEs benefit from 
anticoagulant treatment is increasingly challenged by reports of pa-
tients with ssPEs with an uncomplicated course in the absence of 
treatment.31 In addition, although this should be regarded as indirect 
evidence, population studies have demonstrated that the introduc-
tion of modern CT scanners has led to an increased incidence of PE 
diagnoses without influencing the mortality rate or the 3-month risk 
of VTE among patients left untreated following a negative CTPA.32 
Conversely, diagnostic strategies raising the threshold for perform-
ing CTPA in the setting of suspected PE are associated with a lower 
prevalence of ssPE.33,34 Based on these findings, the latest guide-
lines of the American College of Chest Physicians have suggested 
that in patients with ssPEs and no proximal DVT in the legs who have 
a low risk for recurrent VTE, clinical surveillance is preferred over an-
ticoagulation.35 Definite evidence for the safety of such an approach 
has yet to arrive from a prospective single-arm trial (NCT01455818) 
and a planned randomized controlled trial (NCT04263038). While 
awaiting the results of this trial, our study provides more clarity on 
which conditions, as established by clinical VTE specialists, could 
determine the decision on whether to treat ssPEs. The following 
conditions were considered to necessitate anticoagulant treatment 
in case of either single or multiple subsegmental pulmonary emboli: 
F I G U R E  4   Summary of best clinical practice with regard to management of ssPE resulting from the two rounds of the second part of 
the Delphi analysis. CTPA, computed tomographic pulmonary angiography; DOAC, direct oral anticoagulant; LMWH, low-molecular-weight 
heparin; PE, pulmonary embolism; ssPE, subsegmental pulmonary embolism; VKA, vitamin K antagonist; VTE, venous thromboembolism
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previous VTE, antiphospholipid syndrome, pregnancy, active malig-
nancy, and asymptomatic or symptomatic proximal DVT.
Strengths of this study include the fact that broad and worldwide 
expert panels were surveyed. Second, by selecting a second expert 
panel of VTE specialists, we were able to validate consensus for the 
provided diagnostic criteria in an independent sample of expert cli-
nicians. Third, the results are strengthened by a high level of consen-
sus among the different statements (16/17). In both expert panels, 
participation initial rates were <80%, which forms a limitation of this 
study. Still, consensus was reached easily within both panels, with 
need of few consecutive survey rounds.
In conclusion, this study has provided radiological criteria 
for ssPEs that may be applied in both clinical trials and practice. 
Moreover, we also report best practice for the therapeutic manage-
ment of ssPEs in specific settings as agreed on by the expert cli-
nicians. Future studies should assess to what extent our diagnostic 
criteria improve the sensitivity and interobserver reliability of diag-
nosing ssPEs.
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(“subsegmental pulmonary emboli”[tw] OR “subsegmental pulmo-
nary embolism”[tw] OR “subsegmental pulmonary embolisms”[tw] 
OR “subsegmental pulmonary embolus”[tw] OR “subsegmental 
pe”[tw] OR “subsegmental pes”[tw] OR “subsegmental pulmo-
nary thromboembolism”[tw] OR “subsegmental sized pulmonary 
emboli”[tw] OR “sub segmental acute pe”[tw] OR “sub segmental 
embolisms”[tw] OR “sub segmental pe”[tw] OR “sub segmental pul-
monary embolism”[tw] OR ((“subsegmental”[tw] OR subsegment*[tw] 
OR “sub segmental”[tw] OR sub segment*[tw]) AND (“pulmo-
nary emboli”[tw] OR “pulmonary embolism”[tw] OR “pulmonary 
embolisms”[tw] OR “pulmonary embolus”[tw] OR “pe”[ti] OR 
“pes”[ti] OR “pulmonary thromboembolism”[tw] OR “Pulmonary 
Embolism”[Mesh])) OR (((small branch*[tw] OR smaller branch*[tw] 
OR smallest branch*[tw]) AND (“Pulmonary Artery”[Mesh] OR 
“Pulmonary Artery”[tw] OR “Pulmonary Arteries”[tw])) AND (“pul-
monary emboli”[tw] OR “pulmonary embolism”[tw] OR “pulmo-
nary embolisms”[tw] OR “pulmonary embolus”[tw] OR “pe”[ti] OR 
“pes”[ti] OR “pulmonary thromboembolism”[tw] OR “Pulmonary 
Embolism”[Mesh])) NOT (“Animals”[mesh] NOT “Humans”[mesh]) 
NOT (“Case Reports”[ptyp] OR “case report”[ti]) AND (english[la] 
OR “dutch”[la])) NOT (“subsegmental pulmonary emboli”[ti] OR 
“subsegmental pulmonary embolism”[ti] OR “subsegmental pulmo-
nary embolisms”[ti] OR “subsegmental pulmonary embolus”[ti] OR 
“subsegmental pe”[ti] OR “subsegmental pes”[ti] OR “subsegmental 
pulmonary thromboembolism”[ti] OR “subsegmental sized pulmo-
nary emboli”[ti] OR “sub segmental acute pe”[ti] OR “sub segmental 
embolisms”[ti] OR “sub segmental pe”[ti] OR “sub segmental pulmo-
nary embolism”[ti] OR ((“subsegmental”[ti] OR subsegment*[ti] OR 
“sub segmental”[ti] OR sub segment*[ti]) AND (“pulmonary emboli”[ti] 
OR “pulmonary embolism”[ti] OR “pulmonary embolisms”[ti] OR 
“pulmonary embolus”[ti] OR “pe”[ti] OR “pes”[ti] OR “pulmonary 
thromboembolism”[ti] OR “Pulmonary Embolism”[majr])) OR (((small 
branch*[ti] OR smaller branch*[ti] OR smallest branch*[ti]) AND 
(“Pulmonary Artery”[majr] OR “Pulmonary Artery”[ti] OR “Pulmonary 
Arteries”[ti])) AND (“pulmonary emboli”[ti] OR “pulmonary embolism”[ti] 
OR “pulmonary embolisms”[ti] OR “pulmonary embolus”[ti] OR “pe”[ti] 
OR “pes”[ti] OR “pulmonary thromboembolism”[ti] OR “Pulmonary 
Embolism”[majr])) NOT (“Animals”[mesh] NOT “Humans”[mesh]) NOT
APPENDIX 2
DEPLHI QUESTIONNAIRE SSPE,  EXPERT 
RADIOLOGISTS,  FIRST ROUND
1. In your opinion, should the definition of subsegmental pulmonary em-
bolism on CTPA consist of the following parameters (multiple answers 
possible, please check all that apply)?
A The anatomic location within the pulmonary arterial system.
B The diameter of the pulmonary artery affected.
C The technical quality of the CTPA.
D Other, namely: [free text]
2. What is in your opinion correct?
A pulmonary artery is called subsegmental
A After the first arterial branch has divided off the segmental ar-
tery irrespective of its size (following standard anatomy; Figure 
1).
B As soon as any arterial branch has divided off the segmental ar-
tery irrespective of its size.
C Other, namely: [free text]
3. If a pulmonary artery originates from a division of a clearly identifi-
able segmental artery (following standard anatomy; Figure 1), should the 
vessel diameter be taken into account for the determination whether it is 
subsegmental or not? If yes, what is the maximum diameter size a pulmo-






F Other, namely: [free text]
G The diameter of the affected vessel does not contribute to the 
definition of subsegmental pulmonary embolism.
4. If a pulmonary artery originates from a division of a clearly identifi-
able segmental artery (following standard anatomy; Figure 1), should be 
the anatomic location (eg, peripheral one third of the segment) taken into 
the account for the determination whether it is subsegmental or not? If 
yes, what would be your preference?
A Peripheral one third of the segment.
B Peripheral 50% of the segment.
C The anatomic location does not contribute to the definition of 
subsegmental pulmonary embolism.
D Other, namely [free text]:
5. As a general rule, can the diameter of a certain pulmonary artery 
branch be used to diagnose subsegmental pulmonary embolism? If yes, 






E Other, namely: [free text]
F The diameter of the affected vessel does not contribute to the 
definition of subsegmental pulmonary embolism.
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6. What is the desired maximum collimator width to reliably diagnose 
subsegmental pulmonary embolism?




E Other, namely: [free text]
F The collimator width does not contribute to the diagnosis of sub-
segmental pulmonary embolism.
7. What is the desired Hounsfield Unit in the main pulmonary artery 




D Other, namely: [free text]
E The Hounsfield Unit in the main pulmonary artery does not con-
tribute to the definition of subsegmental pulmonary embolism.
8. Should CT images be routinely reviewed in multiplanar reconstruc-
tions to reliably diagnose subsegmental pulmonary embolism?
A Always.
B Never.
C On demand, namely: [free text]
9. Should CT images be routinely reviewed using maximum intensity 
projections to reliably diagnose subsegmental pulmonary embolism?
A Always.
B Never.
C On demand, namely: [free text]
10. Does perfusion imaging (dual energy or subtraction) help in reli-
ably diagnosing subsegmental pulmonary embolism?
A Always.
B Never.
C Only in selected cases, namely: [free text]
11. What are the imaging criteria for the presence of subsegmental 
pulmonary embolism (several answers are possible)?
A Contrast defect in a subsegmental artery visible in a single axial 
slice.
B Contrast defect in a subsegmental artery visible in at least two 
subsequent axial slices.
C Contrast defect in a subsegmental artery visible in at least two 
directions (axial and coronal or sagittal).
D Sudden contrast drop in a subsegmental artery while arteries of 
comparable diameter in the surrounding show a higher contrast.
E Other, namely: [free text]
12. What are the best window settings to evaluate subsegmental pul-
monary embolism?
A A constant CT angiography window.
B The window/ settings should be adjusted to the intravascular 
contrast.
C The window settings should be modified going from the central 
arteries to the peripheral arteries.
D Other, namely: [free text]
E Window settings do not contribute to the diagnosis of subseg-
mental pulmonary embolism.
13. Should technical specifications of the CT scanner be considered 
for the diagnosis of subsegmental pulmonary embolism?
A At least 4-detector-row CT is sufficient.
B At least 16-detector-row CT is sufficient.
C At least 64-detector-row CT is sufficient.
D Yes, but other, namely: [free text]
E Technical specifications of the CT scanner are not relevant for 
the diagnosis of subsegmental pulmonary embolism.
14. What is the best (systematic) approach of reading a CTPA scan 
that should be used to diagnose subsegmental pulmonary embolism?
A Going from the center to the periphery per lobe.
B Going caudo-cranially or cranio-caudally.
C Other, namely: [free text]
D No systematic approach is necessary for reading CTPA for sub-
segmental pulmonary embolism. 14.9%)
15. The term isolated subsegmental pulmonary embolism refers to:
A A solitary embolus in a single subsegmental artery without the 
presence of additional emboli more centrally.
B The presence of one or multiple subsegmental emboli without 
the presence of additional emboli more centrally.
16. Should the confidence into the diagnosis of subsegmental pulmo-
nary embolism be included into the report?
A Yes, in this way: [free text]
B No.
17. What is the best (systematic) standard of reporting the results of 
CTPA in the setting of suspected pulmonary embolism with regard to the 
subsegmental arteries?
[free text]
